Table 1 (abstract A78). Types of used formulations with respective content of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)[6]
From: Abstracts of the ICARE 2023 77th SIAARTI National Congress
Phytocannabinoid variety | THC content | CBD content | Patients in therapy (1°prescription) |
|---|---|---|---|
Bedrocan | >19% | <1% | 102 |
Bediol | >6% | 7.50% | 14 |
Bedica | >14% | <1% | 11 |
Bedrolite | <1% | 9% | 7 |
FM-2 | 5-8% | 7, 5-12% | 4 |
Pedanios 22-1 | 22% | <1% | 10 |
Farmalabor | >15% | <1% | 21 |